AOP Orphan Pharmaceuticals AG
- A05 - Terapia biliar y hepática
- OCALIVA film-coated tablet 10 mg
- OCALIVA film-coated tablet 5 mg
- B01 - Agentes antitrombóticos
- TREPULMIX solution for infusion 10 mg/10 ml
- TREPULMIX solution for infusion 100 mg/10 ml
- TREPULMIX solution for infusion 25 mg/10 ml
- TREPULMIX solution for infusion 50 mg/10 ml
- TRESUVI solution for infusion 10 mg/10 ml
- TRESUVI solution for infusion 100 mg/10 ml
- TRESUVI solution for infusion 25 mg/10 ml
- TRESUVI solution for infusion 50 mg/10 ml
- C02 - Antihipertensivos
- AMBRISENTAN AOP film-coated tablet 10 mg
- AMBRISENTAN AOP film-coated tablet 5 mg
- C07 - Betabloqueantes
- ESMOCARD powder for solution for infusion 2 500 mg
- ESMOCARD solution for injection 10 mg/ml
- RAPIBLOC concentrate for solution for infusion 20 mg/2 ml
- RAPIBLOC powder for solution for infusion 300 mg
- G04 - Urológicos
- TADALAFIL AOP film-coated tablet 20 mg
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- EMPRESSIN concentrate for solution for injection 40 IU/2 ml
- L01 - Antineoplásicos
- ANAGRELIDE AOP capsule, hard 0.5 mg
- L03 - Inmunoestimulantes
- BESREMI I FÖRFYLLD INJEKTIONSPENNA solution for injection 250 µg/0.5 ml
- BESREMI I FÖRFYLLD INJEKTIONSPENNA solution for injection 500 µg/0.5 ml
- N07 - Otros fármacos activos sobre el sistema nervioso
- NALTREXON VITAFLO film-coated tablet 50 mg
- TETMODIS tablet 25 mg
- WAKIX film-coated tablet 18 mg
- WAKIX film-coated tablet 4.5 mg
- V03 - Todos los demás preparados terapéuticos
- NEXODAL solution for injection 0.4 mg/1 ml